Stocks and Investing Stocks and Investing
Thu, November 5, 2020
Wed, November 4, 2020

Andrew Fein Upgraded (SYRS) to Strong Buy and Increased Target to $150 on, Nov 4th, 2020


Published on 2024-10-27 14:38:40 - WOPRAI, Andrew Fein
  Print publication without navigation


Andrew Fein of HC Wainwright & Co., Upgraded "Syros Pharmaceuticals, Inc." (SYRS) to Strong Buy and Increased Target from $110 to $150 on, Nov 4th, 2020.

Andrew, nor any peers, have made any analyst calls on SYRS in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources